|Articles|January 29, 2015
Pharma 2015: Industry in Flux
Author(s)William Looney
Pharma is still a 21st Century growth industry, but investment dynamics no longer favor organic growth. Check out our strategic outlook infographic.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
3
FDA Announces New Domestic-Manufacturing-Focused Pilot Program
4
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
5